Respir Case Rep. 2016; 5(1): 49-52 | DOI: 10.5505/respircase.2016.83723

Oral Antikoagülan Kullanýmý ile ilgili Nadir Bir Komplikasyon: Diffüz Alveoler Hemoraji (65 Yaþ Üstü 4 Olgu Sunumu)

Serap Duru, Bahar Kurt, Merve Yumrukuz, Esra Erdemir
Dýþkapý Education and Research Hospital, Göðüs Hastalýklarý Kliniði, Ankara, Turkey

Diffüz alveoler hemoraji (DAH), immün ve immün olmayan etyolojik faktörlere baðlý olarak geliþen, akciðerlerde alveolokapiller membranýn hasarý sonucu nefes darlýðý, hemoptizi, anemi, diffüz alveolar konsolidasyon ile karakterize bir hastalýktýr. Burada, kontrolsüz oral antikoagülan (varfarin) kullanýmýna baðlý kanamalar arasýnda nadir görülen bir komplikasyon olan DAH nedeni ile kliniðimizde takip edilen 65 yaþ üstü dört olguyu sunmayý amaçladýk.

Anahtar Kelimeler: Akciðer, varfarin, Diffüz Alveoler Hemoraji.

---

A Rare Complication related with Oral Anticoagulant Use: Diffuse Alveolar Hemorrhage (Over 65 Years; Four Case Reports)

Serap Duru, Bahar Kurt, Merve Yumrukuz, Esra Erdemir
Clinic of Chest Diseases, Dýþkapý Yýdýrým Beyazýt Eðitim Araþtýrma Hastanesi, Ankara

Diffuse alveolar hemorrhage (DAH) caused by immune and non-immune etiological factors, characterized by diffuse alveolar consolidation, often presents with the clinical triad of dyspnea, hemoptysis and, anemia, as a result of the disruption of the alveolocapillary membrane of the lung. We present four cases, when the patients are over 65 years of age, followed up at our clinic with diffuse alveolar hemorrhage as a rare complication of the uncontrolled use of anticoagulant (Warfarin) therapy.

Keywords: Lung, warfarin, Diffuse Alveolar Hemorrhage.

---

ATIF KOPYALA